Search

Kimberly Chong

Examiner (ID: 8669, Phone: (571)272-3111 , Office: P/1674 )

Most Active Art Unit
1635
Art Unit(s)
1636, 1635, 1674
Total Applications
2007
Issued Applications
1153
Pending Applications
209
Abandoned Applications
674

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4451393 [patent_doc_number] => 07964717 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-21 [patent_title] => 'RNAi probes targeting cancer-related proteins' [patent_app_type] => utility [patent_app_number] => 11/276300 [patent_app_country] => US [patent_app_date] => 2006-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 32 [patent_no_of_words] => 7660 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/964/07964717.pdf [firstpage_image] =>[orig_patent_app_number] => 11276300 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/276300
RNAi probes targeting cancer-related proteins Feb 22, 2006 Issued
Array ( [id] => 5620027 [patent_doc_number] => 20060189561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'RNAi expression constructs with liver-specific enhancer/promoter' [patent_app_type] => utility [patent_app_number] => 11/355516 [patent_app_country] => US [patent_app_date] => 2006-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 13479 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20060189561.pdf [firstpage_image] =>[orig_patent_app_number] => 11355516 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/355516
RNAi expression constructs with liver-specific enhancer/promoter Feb 15, 2006 Issued
Array ( [id] => 5253912 [patent_doc_number] => 20070135368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Cell-to-cell transmission of siRNA induced gene silencing in mammalian cells' [patent_app_type] => utility [patent_app_number] => 11/352513 [patent_app_country] => US [patent_app_date] => 2006-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6332 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20070135368.pdf [firstpage_image] =>[orig_patent_app_number] => 11352513 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/352513
Cell-to-cell transmission of siRNA induced gene silencing in mammalian cells Feb 9, 2006 Abandoned
Array ( [id] => 4886522 [patent_doc_number] => 20080260854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Sirna Molecules for the Treatment of Blood Vessels' [patent_app_type] => utility [patent_app_number] => 11/814213 [patent_app_country] => US [patent_app_date] => 2006-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8695 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20080260854.pdf [firstpage_image] =>[orig_patent_app_number] => 11814213 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/814213
siRNA molecules for the treatment of blood vessels Jan 18, 2006 Issued
Array ( [id] => 10008065 [patent_doc_number] => 09051572 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-09 [patent_title] => 'Modulators of Itch ubiquitinase activity' [patent_app_type] => utility [patent_app_number] => 11/813585 [patent_app_country] => US [patent_app_date] => 2006-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 19 [patent_no_of_words] => 27679 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11813585 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/813585
Modulators of Itch ubiquitinase activity Jan 18, 2006 Issued
Array ( [id] => 5601774 [patent_doc_number] => 20060292119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Modulation of negative immune regulators and applications for immunotherapy' [patent_app_type] => utility [patent_app_number] => 11/335736 [patent_app_country] => US [patent_app_date] => 2006-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 113 [patent_figures_cnt] => 113 [patent_no_of_words] => 56794 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20060292119.pdf [firstpage_image] =>[orig_patent_app_number] => 11335736 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/335736
Modulation of negative immune regulators and applications for immunotherapy Jan 18, 2006 Issued
Array ( [id] => 4759919 [patent_doc_number] => 20080312145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Agent for Regulating Bone Formation' [patent_app_type] => utility [patent_app_number] => 11/721834 [patent_app_country] => US [patent_app_date] => 2005-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 8726 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312145.pdf [firstpage_image] =>[orig_patent_app_number] => 11721834 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/721834
Agent for Regulating Bone Formation Dec 14, 2005 Abandoned
Array ( [id] => 4545108 [patent_doc_number] => 07960102 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-14 [patent_title] => 'Regulated aptamer therapeutics' [patent_app_type] => utility [patent_app_number] => 11/291610 [patent_app_country] => US [patent_app_date] => 2005-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13754 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 181 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/960/07960102.pdf [firstpage_image] =>[orig_patent_app_number] => 11291610 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/291610
Regulated aptamer therapeutics Nov 29, 2005 Issued
Array ( [id] => 5596193 [patent_doc_number] => 20060160110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Methods of designing small interfering RNAs, antisense polynucleotides, and other hybridizing polynucleotides' [patent_app_type] => utility [patent_app_number] => 11/290628 [patent_app_country] => US [patent_app_date] => 2005-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17460 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160110.pdf [firstpage_image] =>[orig_patent_app_number] => 11290628 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/290628
Methods of designing small interfering RNAs, antisense polynucleotides, and other hybridizing polynucleotides Nov 28, 2005 Abandoned
Array ( [id] => 5648336 [patent_doc_number] => 20060134068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Treatment of cancer by simultaneous inhibiton of BRAF and restoration or mimicry of p16INK4A activity' [patent_app_type] => utility [patent_app_number] => 11/270796 [patent_app_country] => US [patent_app_date] => 2005-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 24672 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20060134068.pdf [firstpage_image] =>[orig_patent_app_number] => 11270796 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/270796
Treatment of cancer by simultaneous inhibiton of BRAF and restoration or mimicry of p16INK4A activity Nov 7, 2005 Abandoned
Array ( [id] => 5632277 [patent_doc_number] => 20060148747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Antisense antiviral compound and method for treating influenza viral infection' [patent_app_type] => utility [patent_app_number] => 11/259434 [patent_app_country] => US [patent_app_date] => 2005-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13963 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148747.pdf [firstpage_image] =>[orig_patent_app_number] => 11259434 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/259434
Antisense antiviral compound and method for treating influenza viral infection Oct 24, 2005 Issued
Array ( [id] => 5678530 [patent_doc_number] => 20060183886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Ligands to enhance cellular uptake of biomolecules' [patent_app_type] => utility [patent_app_number] => 11/256476 [patent_app_country] => US [patent_app_date] => 2005-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 24433 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183886.pdf [firstpage_image] =>[orig_patent_app_number] => 11256476 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/256476
Ligands to enhance cellular uptake of biomolecules Oct 20, 2005 Abandoned
Array ( [id] => 4792679 [patent_doc_number] => 20080293653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Method of treating autoimmune diseases' [patent_app_type] => utility [patent_app_number] => 11/247331 [patent_app_country] => US [patent_app_date] => 2005-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 20399 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293653.pdf [firstpage_image] =>[orig_patent_app_number] => 11247331 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/247331
Method of treating autoimmune diseases Oct 11, 2005 Abandoned
Array ( [id] => 12192968 [patent_doc_number] => 09896687 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-02-20 [patent_title] => 'Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure' [patent_app_type] => utility [patent_app_number] => 11/233495 [patent_app_country] => US [patent_app_date] => 2005-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15422 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11233495 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/233495
Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure Sep 20, 2005 Issued
Array ( [id] => 8232790 [patent_doc_number] => 08198235 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-12 [patent_title] => 'Use of GILZ protein expressed in dendritic cells to modulate an antigen-specific immune response' [patent_app_type] => utility [patent_app_number] => 11/575073 [patent_app_country] => US [patent_app_date] => 2005-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8466 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/198/08198235.pdf [firstpage_image] =>[orig_patent_app_number] => 11575073 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/575073
Use of GILZ protein expressed in dendritic cells to modulate an antigen-specific immune response Sep 8, 2005 Issued
Array ( [id] => 5801261 [patent_doc_number] => 20060035815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Pharmaceutical compositions for delivery of ribonucleic acid to a cell' [patent_app_type] => utility [patent_app_number] => 11/223699 [patent_app_country] => US [patent_app_date] => 2005-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 27772 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20060035815.pdf [firstpage_image] =>[orig_patent_app_number] => 11223699 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/223699
Pharmaceutical compositions for delivery of ribonucleic acid to a cell Sep 7, 2005 Abandoned
Array ( [id] => 5710982 [patent_doc_number] => 20060052327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Cell specific gene silencing using cell-specific promoters in vitro and in vivo' [patent_app_type] => utility [patent_app_number] => 11/221096 [patent_app_country] => US [patent_app_date] => 2005-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10305 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20060052327.pdf [firstpage_image] =>[orig_patent_app_number] => 11221096 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/221096
Cell specific gene silencing using cell-specific promoters in vitro and in vivo Sep 6, 2005 Abandoned
Array ( [id] => 5591432 [patent_doc_number] => 20060040884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Antisense oligonucleotides directed to genes regulated by trapoxin-induced HDAC inhibition' [patent_app_type] => utility [patent_app_number] => 11/191875 [patent_app_country] => US [patent_app_date] => 2005-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26538 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20060040884.pdf [firstpage_image] =>[orig_patent_app_number] => 11191875 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/191875
Antisense oligonucleotides directed to genes regulated by trapoxin-induced HDAC inhibition Jul 27, 2005 Abandoned
Array ( [id] => 5441419 [patent_doc_number] => 20090093058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'CELL TRANSFECTION ARRAY FOR INTRODUCTION OF NUCLEIC ACID' [patent_app_type] => utility [patent_app_number] => 11/996002 [patent_app_country] => US [patent_app_date] => 2005-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4730 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20090093058.pdf [firstpage_image] =>[orig_patent_app_number] => 11996002 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/996002
Cell transfection array for introduction of nucleic acid Jul 21, 2005 Issued
Array ( [id] => 5880920 [patent_doc_number] => 20060030003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Composition and method for introduction of RNA interference sequences into targeted cells and tissues' [patent_app_type] => utility [patent_app_number] => 11/186609 [patent_app_country] => US [patent_app_date] => 2005-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5276 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20060030003.pdf [firstpage_image] =>[orig_patent_app_number] => 11186609 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/186609
Composition and method for introduction of RNA interference sequences into targeted cells and tissues Jul 20, 2005 Abandoned
Menu